Nombre del producto:spiro[indene-1,2'-[1,3]dioxolane]

IUPAC Name:spiro[1,3-dioxolane-2,1'-indene]

CAS:6710-43-6
Fórmula molecular:C11H10O2
Pureza:95%
Número de catálogo:CM138931
Peso molecular:174.2

Unidad de embalaje Stock disponible Precio($) Cantidad
CM138931-1g in stock ȀNJNJ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :6710-43-6
Fórmula molecular:C11H10O2
Punto de fusión:-
Código de sonrisas:C12=C(C3(C=C2)OCCO3)C=CC=C1
Densidad:
Número de catálogo:CM138931
Peso molecular:174.2
Punto de ebullición:
Nº Mdl:
Almacenamiento:Store at 2-8°C.

Category Infos

Dioxolanes
Dioxolane is a heterocyclic acetal with the formula (CH2)2O2CH2. It is related to tetrahydrofuran by exchanging an oxygen for the CH2 group. The isomer 1,2-dioxolane (in which the two oxygen centers are adjacent) is a peroxide. 1,3-Dioxolane is used as solvent and comonomer in polyacetal. The dioxolane-type and their hydrogenolysis can provide very valuable partially protected building blocks either for oligosaccharide syntheses or sugar transformations.
Indenes
Indenes are useful building blocks found in a variety of biologically relevant products.

Column Infos

Spiro Compounds
A spiro compound is a polycyclic compound in which two monocyclic rings share one carbon atom; the shared carbon atom is called a spiro atom. Spiro compounds have rigid structures, stable structures, and have special properties that general organic compounds do not possess, such as anomeric effect, spiro conjugation and spiro hyperconjugation. Compared with the monocyclic structure or the planar aromatic structure, the spiro structure has a larger three-dimensional structure; the heterocyclic spiro structure is also regarded as the biological isostere of some groups, which can change the drug to a certain extent. The water solubility, lipophilicity, dominant conformation and ADMET properties of the molecule make the optimized lead molecule easier to drug. Therefore, spiro compounds occupy a very important position in drug development.